MarketCap
Facebook
X
TelegramVarian Medical Systems, Inc. Balance Sheet 2011-2026 | VAR
Annual Balance Sheet Varian Medical Systems, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-411 M | -121 M | -505 M | -366 M | -176 M | -400 M | -412 M | -612 M | -543 M | -367 M |
Long Term Debt |
- | - | - | - | 288 M | 338 M | 388 M | 450 M | 6.3 M | 6.25 M |
Total Non Current Liabilities |
421 M | 449 M | 329 M | 132 M | 458 M | 490 M | 539 M | 594 M | 132 M | 129 M |
Total Current Liabilities |
1.85 B | 1.88 B | 1.34 B | 1.65 B | 1.61 B | 1.38 B | 1.2 B | 1.16 B | 1.24 B | 1.13 B |
Total Liabilities |
2.38 B | 2.33 B | 1.67 B | 1.78 B | 2.07 B | 1.87 B | 1.74 B | 1.75 B | 1.37 B | 1.25 B |
Deferred Revenue |
782 M | 766 M | 730 M | 641 M | 621 M | 490 M | 422 M | 389 M | 131 M | 440 M |
Retained Earnings |
1.13 B | 934 M | 780 M | 779 M | 1.07 B | 1.1 B | 931 M | 1.01 B | 893 M | 677 M |
Total Assets |
4.46 B | 4.1 B | 3.25 B | 3.29 B | 3.82 B | 3.58 B | 3.36 B | 3.47 B | 2.88 B | 2.5 B |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Varian Medical Systems, Inc., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical instruments
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
$ 184.86 | 1.31 % | $ 53.2 B | USA |
 |
Baxter International
BAX
|
$ 21.74 | 1.85 % | $ 11.2 B | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
$ 11.29 | -8.21 % | $ 228 M | USA |
 |
ICU Medical
ICUI
|
$ 155.85 | 4.08 % | $ 3.84 B | USA |
 |
Alcon
ALC
|
$ 82.21 | -1.21 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
$ 32.79 | 1.27 % | $ 1.57 B | USA |
 |
electroCore
ECOR
|
$ 6.16 | -0.16 % | $ 34 K | USA |
 |
Harvard Bioscience
HBIO
|
$ 0.58 | -0.56 % | $ 24.6 M | USA |
 |
LeMaitre Vascular
LMAT
|
$ 92.55 | 0.75 % | $ 2.08 B | USA |
 |
AngioDynamics
ANGO
|
$ 11.22 | 0.13 % | $ 458 M | USA |
 |
InfuSystem Holdings
INFU
|
$ 7.9 | - | $ 163 M | USA |
 |
The Cooper Companies
COO
|
$ 84.11 | 0.51 % | $ 16.7 B | USA |
 |
Haemonetics Corporation
HAE
|
$ 61.61 | 1.55 % | $ 3.1 B | USA |
 |
iRhythm Technologies
IRTC
|
$ 150.56 | -5.24 % | $ 4.82 B | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
$ 119.69 | 2.21 % | $ 5.8 B | USA |
 |
Repro Med Systems
KRMD
|
$ 4.72 | 0.64 % | $ 215 M | USA |
 |
OraSure Technologies
OSUR
|
$ 2.76 | -2.47 % | $ 205 M | USA |
 |
Masimo Corporation
MASI
|
$ 175.38 | 0.03 % | $ 9.35 B | USA |
 |
Intuitive Surgical
ISRG
|
$ 504.2 | 0.93 % | $ 180 B | USA |
 |
Merit Medical Systems
MMSI
|
$ 82.25 | 0.5 % | $ 4.79 B | USA |
 |
Microbot Medical
MBOT
|
$ 2.07 | -3.95 % | $ 21.1 M |  Israel |
 |
Nephros
NEPH
|
$ 4.14 | 6.43 % | $ 43 M | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | USA |
 |
Milestone Scientific
MLSS
|
$ 0.26 | -2.04 % | $ 20.7 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 12.63 | 0.88 % | $ 2.57 B | USA |
 |
Envista Holdings Corporation
NVST
|
$ 29.16 | 1.53 % | $ 4.9 B | USA |
 |
Pro-Dex
PDEX
|
$ 39.55 | 1.41 % | $ 130 M | USA |
 |
Pulse Biosciences
PLSE
|
$ 21.98 | -12.38 % | $ 1.48 B | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | USA |
 |
Stereotaxis
STXS
|
$ 2.08 | -0.24 % | $ 168 M | USA |
 |
Repligen Corporation
RGEN
|
$ 136.76 | -0.34 % | $ 7.62 M | USA |
 |
ResMed
RMD
|
$ 258.04 | 0.68 % | $ 37.7 B | USA |
 |
BioLife Solutions
BLFS
|
$ 23.17 | -0.26 % | $ 1.07 B | USA |
 |
STERIS plc
STE
|
$ 250.32 | -0.34 % | $ 24.7 B | USA |
 |
Retractable Technologies
RVP
|
$ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
STAAR Surgical Company
STAA
|
$ 17.65 | -1.29 % | $ 867 M | USA |
 |
Teleflex Incorporated
TFX
|
$ 115.88 | 3.65 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
$ 67.96 | 2.09 % | $ 247 M | USA |
 |
West Pharmaceutical Services
WST
|
$ 241.54 | -0.94 % | $ 17.5 B | USA |